Enhancing Efficacy of Anticancer Vaccines by Targeted Delivery to Tumor-Draining Lymph Nodes

作者
Laura Jeanbart,Marie Christine Ballester,Alexandre de Titta,Patricia Corthésy,Pedro J. Romero,Jeffrey A. Hubbell,Melody A. Swartz
出处
期刊:Cancer immunology research [American Association for Cancer Research]
卷期号:2 (5): 436-447 被引量:191
标识
DOI:10.1158/2326-6066.cir-14-0019-t
摘要

The sentinel or tumor-draining lymph node (tdLN) serves as a metastatic niche for many solid tumors and is altered via tumor-derived factors that support tumor progression and metastasis. tdLNs are often removed surgically, and therapeutic vaccines against tumor antigens are typically administered systemically or in non-tumor-associated sites. Although the tdLN is immune-suppressed, it is also antigen experienced through drainage of tumor-associated antigens (TAA), so we asked whether therapeutic vaccines targeting the tdLN would be more or less effective than those targeting the non-tdLN. Using LN-targeting nanoparticle (NP)-conjugate vaccines consisting of TAA-NP and CpG-NP, we compared delivery to the tdLN versus non-tdLN in two different cancer models, E.G7-OVA lymphoma (expressing the nonendogenous TAA ovalbumin) and B16-F10 melanoma. Surprisingly, despite the immune-suppressed state of the tdLN, tdLN-targeting vaccination induced substantially stronger cytotoxic CD8+ T-cell responses, both locally and systemically, than non-tdLN-targeting vaccination, leading to enhanced tumor regression and host survival. This improved tumor regression correlated with a shift in the tumor-infiltrating leukocyte repertoire toward a less suppressive and more immunogenic balance. Nanoparticle coupling of adjuvant and antigen was required for effective tdLN targeting, as nanoparticle coupling dramatically increased the delivery of antigen and adjuvant to LN-resident antigen-presenting cells, thereby increasing therapeutic efficacy. This work highlights the tdLN as a target for cancer immunotherapy and shows how its antigen-experienced but immune-suppressed state can be reprogrammed with a targeted vaccine yielding antitumor immunity.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科目三的应助被云雀采纳,获得10
刚刚
zclm发布了新的文献求助10
1秒前
waka发布了新的文献求助30
1秒前
1秒前
1秒前
CC关注了科研通微信公众号
1秒前
1秒前
KK完成签到,获得积分10
2秒前
2秒前
Docsiwen发布了新的文献求助10
2秒前
重生之学术裁缝逐梦学术圈完成签到,获得积分10
2秒前
研友_ngkEgn完成签到,获得积分10
2秒前
xing_xing的应助被屿111采纳,获得20
2秒前
马达加斯加小企鹅完成签到 ,获得积分10
3秒前
光光完成签到 ,获得积分10
3秒前
烊烊烊完成签到,获得积分10
3秒前
4秒前
kiwi完成签到,获得积分10
4秒前
4秒前
4秒前
情怀的应助被soda采纳,获得10
4秒前
黑米粥发布了新的文献求助200
5秒前
完美世界的应助被小苏打采纳,获得10
5秒前
LFY完成签到,获得积分10
5秒前
qi发布了新的文献求助10
6秒前
郝子凯发布了新的文献求助10
6秒前
本本完成签到,获得积分10
6秒前
yyc发布了新的文献求助10
7秒前
7秒前
7秒前
Hello的应助被Daisy采纳,获得10
8秒前
yurise发布了新的文献求助10
8秒前
兴奋石头发布了新的文献求助10
8秒前
Cataphyll完成签到,获得积分10
8秒前
9秒前
xyh发布了新的文献求助10
9秒前
9秒前
wanci的应助被村上种树采纳,获得10
10秒前
11秒前
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187592
求助须知:如何正确求助?哪些是违规求助? 9575705
关于积分的说明 21842471
捐赠科研通 7785407
什么是DOI,文献DOI怎么找? 3435057
关于科研通互助平台的介绍 2559461
邀请新用户注册赠送积分活动 2481952